US Stock Market Move | The company expects the operating profit to be positive in 2025 and BEIGENE (ONC.US) has risen by over 7%.
On Tuesday, BeiGene (ONC.US) rose more than 7%, closing at $197.77.
On Tuesday, BEIGENE (ONC.US) rose more than 7% to $197.77. The company will participate in and present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13, 2025 (Eastern Time). CEO Mr. Oulei Qiang mentioned that the company is expected to achieve positive full-year operating profit in 2025 under US GAAP (i.e. operating revenue greater than the sum of operating costs, sales expenses, management expenses, and R&D expenses).
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
